Literature DB >> 10074643

Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces.

H P Wendel1, A M Scheule, F S Eckstein, G Ziemer.   

Abstract

Extracorporeal circulation (ECC) in paediatric patients with heparin-coated oxygenation systems is rarely investigated. The objective of this study was to evaluate, preclinically, the haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces. We compared 16 paediatric membrane oxygenators (Minimax, Medtronic) in an in vitro heart-lung machine model with fresh human blood. Eight of these oxygenation systems had a covalent heparin coating (Carmeda bioactive surface). After 90 min simulated ECC, the heparin-coated systems showed significantly higher platelet count, lower platelet-factor 4 release, reduced contact activation (factor XIIa and kallikrein), and lower neutrophil elastase levels (p < 0.05), compared to the noncoated oxygenator group. More biocompatible materials for paediatric operations may ameliorate the various postperfusion syndromes arising from ECC procedures, particularly unspecific inflammation, hyperfibrinolysis and blood loss.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074643     DOI: 10.1177/026765919901400104

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  7 in total

Review 1.  COVID-19 and Extracorporeal Membrane Oxygenation.

Authors:  Gennaro Martucci; Artur Słomka; Steven Eric Lebowitz; Giuseppe Maria Raffa; Pietro Giorgio Malvindi; Valeria Lo Coco; Justyna Swol; Ewa Żekanowska; Roberto Lorusso; Waldemar Wierzba; Piotr Suwalski; Mariusz Kowalewski
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Plasma contact factors as therapeutic targets.

Authors:  Benjamin F Tillman; Andras Gruber; Owen J T McCarty; David Gailani
Journal:  Blood Rev       Date:  2018-04-12       Impact factor: 8.250

Review 3.  Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.

Authors:  Terry C Major; Hitesh Handa; Gail M Annich; Robert H Bartlett
Journal:  J Biomater Appl       Date:  2014-06-16       Impact factor: 2.646

Review 4.  Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial Surfaces.

Authors:  Benjamin Tillman; David Gailani
Journal:  Semin Thromb Hemost       Date:  2017-09-12       Impact factor: 4.180

Review 5.  The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology.

Authors:  Jonathan E Millar; Jonathon P Fanning; Charles I McDonald; Daniel F McAuley; John F Fraser
Journal:  Crit Care       Date:  2016-11-28       Impact factor: 9.097

6.  Insult to Injury: Development of Alveolar Hemorrhage after Initiation of Extracorporeal Membrane Oxygenation.

Authors:  Sarah Williams; Kiran Batra; Manish Mohanka; Srinivas Bollineni; Vaidehi Kaza; Fernando Torres; Amit Banga
Journal:  Indian J Crit Care Med       Date:  2020-12

Review 7.  Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review.

Authors:  Sasa Rajsic; Robert Breitkopf; Dragana Jadzic; Marina Popovic Krneta; Helmuth Tauber; Benedikt Treml
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.